Price Alert

Amphastar Pharmaceuticals... (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

30.09

-0.12 (-0.40%)

At close: Aug 15, 2025, 3:13 PM

Amphastar Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	720.28M	728.26M	729.57M	721.15M	712.89M	676.21M	644.39M	601.31M	540.89M	518.64M	498.99M	484.85M	476.92M	455.12M	437.77M	412.8M	384.04M	368.18M
Cost of Revenue	359.95M	362.38M	361.64M	346.31M	331.58M	314.21M	295.85M	275.16M	264.63M	251.77M	250.13M	250.93M	250.32M	244.5M	238.03M	232.47M	218.37M	216.72M
Gross Profit	360.33M	365.89M	367.93M	374.85M	381.31M	362M	348.55M	326.15M	276.26M	266.87M	248.86M	233.93M	226.6M	210.62M	199.74M	180.34M	165.66M	151.46M
Operating Income	181.67M	194.7M	205.42M	214.25M	229.88M	211.56M	189.59M	173.44M	116.5M	104.43M	107.78M	94.2M	103.23M	88.97M	69.89M	48.51M	27.26M	13.78M
Interest Income	8.73M	10.14M	10.61M	10.62M	9.4M	7.09M	5.46M	3.74M	2.87M	2.06M	1.32M	898K	708K	621K	601K	574K	594K	650K
Pretax Income	161.84M	172.75M	189.19M	186.07M	201.63M	184.2M	170.46M	170.88M	130.23M	120.58M	116.04M	101.94M	116.99M	108.06M	84.14M	50.23M	19.67M	3.95M
Net Income	134.71M	141.63M	159.52M	157.72M	166.51M	154.69M	137.54M	135.29M	101.94M	93.17M	91.39M	77.23M	90.91M	81.33M	62.12M	36.08M	10.45M	2.5M
Selling & General & Admin	99.27M	97.34M	94.52M	92.9M	88.14M	84.84M	80.39M	74.75M	72.46M	69.19M	66.59M	65.19M	64.08M	67.03M	68.92M	70.04M	69.74M	70.99M
Research & Development	79.39M	76.97M	71.1M	70.81M	66.4M	65.59M	71.17M	70.56M	72.41M	78.36M	74.77M	74.82M	67.07M	62.39M	60.93M	61.78M	68.66M	66.69M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	136K	136K	136K	136K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	178.66M	174.3M	165.63M	163.71M	154.54M	150.43M	151.56M	145.31M	144.87M	147.56M	141.36M	140.01M	131.14M	129.42M	129.85M	131.82M	138.4M	137.68M
Interest Expense	25.69M	28.02M	30.34M	33.37M	40.38M	35.37M	27.16M	18.23M	5.09M	1.89M	1.85M	1.49M	1.45M	1.14M	885K	805K	453K	402K
Selling & Marketing Expenses	41.52M	40.3M	37.8M	36M	33.41M	31.11M	28.85M	25.71M	24.08M	23.12M	21.53M	20.13M	20.09M	18.47M	17.49M	17.2M	16.13M	16.02M
Cost & Expenses	538.62M	533.56M	524.15M	506.9M	483.01M	464.64M	447.41M	420.47M	409.5M	399.32M	391.49M	390.93M	381.46M	373.92M	367.88M	364.29M	356.77M	354.4M
Income Tax Expense	27.13M	31.12M	29.67M	28.35M	35.12M	29.21M	31.83M	34.45M	26.98M	26.15M	23.48M	23.38M	23.51M	23.55M	20.63M	12.49M	8.09M	2.42M
Shares Outstanding (Basic)	46.95M	47.64M	48.43M	48.62M	48.91M	48.21M	47.96M	48.7M	48.4M	48M	48.3M	52.79M	48.86M	51.6M	47.84M	48.02M	47.73M	47.52M
Shares Outstanding (Diluted)	48.13M	49.89M	52.06M	51.86M	52.05M	53.01M	53.01M	53.92M	53.1M	51.97M	51.72M	52.79M	53.23M	51.98M	50.06M	50.01M	49.55M	49.52M
EPS (Basic)	2.80	2.92	3.29	3.26	3.44	3.20	2.84	2.79	2.08	1.89	1.82	1.53	1.85	1.66	1.30	0.76	0.22	0.06
EPS (Diluted)	2.67	2.76	3.06	3.00	3.13	2.89	2.58	2.56	1.95	1.79	1.76	1.49	1.78	1.61	1.24	0.72	0.21	0.05
EBITDA	248.07M	255.58M	265.2M	267.92M	290.01M	264.08M	243.47M	224.93M	157.24M	138.64M	133.46M	118.11M	139.57M	135.92M	111.78M	78.01M	47.25M	30.53M
EBIT	187.53M	197.13M	208M	211.59M	234.55M	216.22M	202.18M	186.03M	131.92M	119.85M	107.5M	97M	98.54M	84.27M	72.97M	38.98M	17.73M	5.7M
Depreciation & Amortization	60.54M	58.45M	57.2M	56.33M	55.47M	48.34M	41.78M	35.42M	29.34M	29.34M	28.74M	27.86M	26.88M	26.72M	26.75M	26.97M	27.13M	26.18M